How long can 35-year-old myocardial hypertrophy live is related to the severity of myocardial hypertrophy, whether or not to receive standardized treatment, survival time can not be determined. 35-year-old myocardial hypertrophy may be due to hypertension, hypertrophic cardiomyopathy, etc., after active standardized treatment generally does not affect the life expectancy. If compensatory cardiac hypertrophy is caused by hypertension, active control of blood pressure is needed, and the survival time is longer. If the blood pressure is poorly controlled for a long time, it may cause pathological myocardial hypertrophy, which may lead to heart failure and affect life expectancy. If hypertrophic cardiomyopathy caused by myocardial hypertrophy, under the guidance of a doctor, the application of beta-blockers such as metoprolol succinate or calcium channel blockers such as verapamil to reduce the left ventricular outflow tract obstruction, patients with mild myocardial hypertrophy to actively carry out the treatment will not affect the patient’s life expectancy, while patients with severe myocardial hypertrophy may experience heart failure or even sudden death. Myocardial hypertrophy patients should go to the hospital regularly for review, and follow the doctor’s instructions for standardized treatment, so as to avoid delays in the condition, resulting in adverse consequences.